Litcius/Paper detail

Differences between zoledronic acid and denosumab for breast cancer treatment

Takashi Ishikawa

2023Journal of Bone and Mineral Metabolism16 citationsDOI

Topics & Concepts

Zoledronic acidDenosumabMedicineBreast cancerOncologyInternal medicineBone Density Conservation AgentsCancerOsteoporosisBone densityBone health and treatmentsBone and Joint DiseasesOsteomyelitis and Bone Disorders Research
Differences between zoledronic acid and denosumab for breast cancer treatment | Litcius